Key Treatment Principles and Recent Updates In the Management of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Chronic lymphocytic leukemia is a lymphoproliferative disorder characterized by the accumulation of circulating ...

JANUARY 9, 2025

FDA Approves Fibryga for Acquired Fibrinogen Deficiency

The FDA expanded the approval for Fibryga to include fibrinogen replacement in bleeding patients with acquired ...

AUGUST 6, 2024

New Developments in Hemophilia Gene Therapy

Hemophilia is an X chromosome–linked genetic bleeding disorder caused by absent or defective clotting factor, ...

MAY 30, 2024

FDA Approves Bkemv, Interchangeable Biosimilar to Soliris

The FDA approved Bkemv as the first interchangeable biosimilar to Soliris to treat two rare diseases that cause red ...

MAY 30, 2024

Is It Time for Next-Generation Cancer Sequencing?

Unlike current assays such as flow cytometry (FCM), NGS assays employ unique genetic sequences in leukemia cells ...

MARCH 10, 2022

New CAR-T Data, Other Lymphoma Therapy Insights

In advanced forms of lymphoma, an avalanche of new data with chimeric antigen receptor (CAR) T cells was presented ...

JANUARY 14, 2022

New SCD Pain Recs Call For Individualized Care

People living with chronic pain due to sickle cell disease (SCD) should be managed with a variety of pharmacologic ...

OCTOBER 20, 2020